ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Archives for August 2018

KEYNOTE-042: No Hard and Fast Rules for First-Line Pembrolizumab Regarding PD-L1–Positive Disease

on: August 27, 2018In: Systemic, Targeted, & Immune Therapies
KEYNOTE-042: No Hard and Fast Rules for First-Line Pembrolizumab Regarding PD-L1–Positive
            Disease

By Kara Nyberg, PhD Posted: August 2018 The pace of research focused on new therapies for advanced NSCLC has progressed from a trot to a sprint in recent years. Among […] Read more


Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research

on: August 27, 2018In: Evolving Standards of Care
Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research

By Caroline Dive, CBE, PhD, FMedSci, and Kris Frese, PhD Posted: August 2018 Small cell lung cancer (SCLC) is aggressive, disseminates early, and has a dismal prognosis.1 Its genomic landscape […] Read more

NCI Selects Five Teams of Researchers to Expand Discovery of Predictive Biomarkers for Immunotherapy

on: August 27, 2018In: Regulatory Agency Perspective
NCI Selects Five Teams of Researchers to Expand Discovery of Predictive Biomarkers for Immunotherapy

Posted: August 2018 In October 2017, the United States National Cancer Institute (NCI) launched a major effort to expand the discovery and validation of predictive biomarkers on cancer immunotherapy. This […] Read more

The Budget Landscape with Dr. Douglas R. Lowy

on: August 27, 2018In: Regulatory Agency Perspective
The Budget Landscape with Dr. Douglas R. Lowy

By Erik MacLaren, PhD Posted: August 2018 The National Cancer Institute (NCI) and researchers who rely on the funding it provides have spent much of the past year under the […] Read more

The IASLC Issues Liquid Biopsy Statement to Aid Understanding of Rapid Innovation

on: August 27, 2018In: Evolving Standards of Care
The IASLC Issues Liquid Biopsy Statement to Aid Understanding of Rapid Innovation

By Joy Curzio Posted: August 2018 Liquid biopsy is a powerful tool that can determine a patient’s molecular tumor profile and aid diagnosis, as well as therapeutic choices. Liquid biopsy […] Read more

Global Insights on New Clinical Practice Guideline for the Treatment of Malignant Pleural Mesothelioma

on: August 27, 2018In: Evolving Standards of Care
Global Insights on New Clinical Practice Guideline for the Treatment of Malignant Pleural Mesothelioma

By Hedy L. Kindler, MD Posted: August 2018 The American Society of Clinical Oncology (ASCO) has issued its first-ever clinical practice guidelines on the management of patients with malignant pleural […] Read more

Updated Results from the Phase III ALEX Trial: Embracing Hazard Ratios

on: August 27, 2018In: Systemic, Targeted, & Immune Therapies
Updated Results from the Phase III ALEX Trial: Embracing Hazard Ratios

By D. Ross Camidge, MD, and Mary W. Redman, PhD Posted: August 2018 Updates of the primary analysis of the phase III ALEX trial were presented at the American Society […] Read more

WCLC Plenary Symposia to Include Practice-Changing Research Presentations

on: August 27, 2018In: Meeting News
WCLC Plenary Symposia to Include Practice-Changing Research Presentations

The conference’s program is stacked with science and education for scientists, clinicians, and advocates alike. By Leah K. Lawrence Posted: August 2018 The IASLC 19th World Conference on Lung Cancer […] Read more

Avrum Spira, MD

on: August 27, 2018In: Names & News
Avrum Spira, MD

Posted: August 2018 Avrum Spira, MD, has been named global head of the new Lung Cancer Initiative within Johnson & Johnson, which will be based at Boston University’s Medical Campus. […] Read more

Christian Rolfo, MD, PhD, MBA

on: August 27, 2018In: Names & News
Christian Rolfo, MD, PhD, MBA

Posted: August 2018 As of April 2018, Christian Rolfo, MD, PhD, MBA, is the director of the Thoracic Medical Oncology and the Early Clinical Trials at the University of Maryland […] Read more

12

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy